Patents by Inventor Jingling Tang

Jingling Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New Treatment of Sepsis
    Publication number: 20240148788
    Abstract: The present invention relates to a method for treatment of sepsis in a subject comprising administering a pharmaceutical composition comprising an effective amount of allogeneic Natural Killer cells to said subject, and to methods for predicting a subject's susceptibility to such method of treatment.
    Type: Application
    Filed: March 23, 2022
    Publication date: May 9, 2024
    Inventors: Yuan Yang, Jingling Tang, Pingsheng Hu, Xiaoyang Li, Liyun Wu
  • MODIFIED T CELLS FOR ADOPTIVE IMMUNOTHERAPY
    Publication number: 20240093149
    Abstract: The present invention relates to population of T cells with reduced expression of SIGLEC15, wherein the T cells are derived from sentinel lymph nodes in a subject having a cancer. The invention also relates to methods for obtaining such T cells, as well as to their use in therapy and pharmaceutical compositions comprising such T cells.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 21, 2024
    Inventors: Yuan Yang, Hang Du, Jingling Tang, Pingsheng Hu